Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LCAV

LCA-Vision (LCAV) Stock Price, News & Analysis

About LCA-Vision Stock (NASDAQ:LCAV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

LCA-Vision Inc. is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. The Company's vision centers provide the staff, facilities, equipment and support services for performing laser vision correction that employ advanced laser technologies to help correct nearsightedness, farsightedness and astigmatism. The Company's vision centers are supported by independent, ophthalmologists and credentialed optometrists, as well as other healthcare professionals. The ophthalmologists perform the laser vision correction procedures in the Company's vision centers, and ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-up care in-center. Most of the Company's patients receive a procedure called laser-assisted in situ keratomileusis (LASIK). As of December 31, 2011, it had performed over 1.2 million laser vision correction procedures in its vision centers in the United States and Canada.

Receive LCAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LCA-Vision and its competitors with MarketBeat's FREE daily newsletter.

LCAV Stock News Headlines

URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.
LCAV Historical Data
Apple Vision Pro
See More Headlines

LCAV Stock Analysis - Frequently Asked Questions

LCA-Vision Inc. (NASDAQ:LCAV) released its quarterly earnings data on Wednesday, April, 30th. The healthcare company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.23 by $0.24. The healthcare company had revenue of $25.53 million for the quarter, compared to analysts' expectations of $32.04 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that LCA-Vision investors own include Gen Digital (GEN), Amyris (AMRS), American Superconductor (AMSC), Digital Turbine (APPS), Athersys (ATHX), AVEO Pharmaceuticals (AVEO) and Bloom Energy (BE).

Company Calendar

Last Earnings
4/30/2014
Today
4/25/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:LCAV
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:LCAV) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners